349348
Platinum
foil, thickness 0.127 mm, 99.99% trace metals basis
Sinónimos:
Platinum black, Platinum element
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
About This Item
Productos recomendados
Quality Level
assay
99.99% trace metals basis
form
foil
resistivity
10.6 μΩ-cm, 20°C
thickness
0.127 mm
bp
3827 °C (lit.)
mp
1772 °C (lit.)
density
21.45 g/cm3 (lit.)
SMILES string
[Pt]
InChI
1S/Pt
InChI key
BASFCYQUMIYNBI-UHFFFAOYSA-N
Quantity
1.7 g = 25 × 25 mm; 7 g = 50 × 50 mm
Storage Class
13 - Non Combustible Solids
wgk_germany
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Los clientes también vieron
Journal of biomedical nanotechnology, 9(2), 274-280 (2013-05-01)
Noninvasive molecular fluorescence imaging in vivo which combines Optical imaging with genetic marker technology can real time monitor the development of tumor, through the use of human adenoid cystic carcinoma cell (ACC-M) and lung carcinoma cells SPC-A1 were thansfected by
BMC structural biology, 13, 4-4 (2013-03-23)
To explore novel platinum-based anticancer agents that are distinct from the structure and interaction mode of the traditional cisplatin by forming the bifunctional intrastrand 1,2 GpG adduct, the monofunctional platinum+DNA adducts with extensive non-covalent interactions had been studied. It was
Journal of nanoscience and nanotechnology, 13(1), 306-314 (2013-05-08)
Multi-walled carbon nanotube grafted Pt nanoparticles via nitrogen atom (MWCNT-N-Pt) has chemically synthesized and characterized as an efficient oxygen reduction reaction (ORR) catalysts. Structural and morphological properties of the electrocatalyst have characterized by transmission electron microscopy (TEM), energy-dispersive X-ray spectroscopy
Japanese journal of clinical oncology, 43(6), 664-668 (2013-04-16)
Interstitial lung disease associated with gefitinib is a critical adverse reaction. When geftinib was administered to EGFR-unknown patients, the interstitial lung disease incidence rate was approximately 3-4% in Japan, and usually occurs during the first 4 weeks of treatment. However
Catalysis: The accelerator.
Nature, 495(7440), S10-S11 (2013-03-15)
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico